Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Package design helping GSK, FDA to identify bogus Alli pills

Differences in markings on primary and secondary packages, as well as the bottle and cap structure, make it simpler for consumers to identify the potentially harmful pills.

GlaxoSmithKline (GSK) is a front-runner among pharmaceutical product marketers in understanding the value of package design. That knowledge is paying off on the store shelf through brand identity with shoppers, and now it’s apparent that package design also will help the company’s brand-protection effort.

Word comes from the Food and Drug Administration, and detailed on AboutLawsuits.com, that counterfeiters are putting a knock-off version of GSK’s Alli weight-loss pills on the market via the Internet. Besides the counterfeiting issue, the fake Alli pills include a controlled substance that could be harmful to people taking other medications.

Counterfeit drugs are commonplace around the world, but in Alli’s case, both the primary and secondary packages are helping consumers to identify the fake pills from the real deal. Besides different markings on various components of the packaging, two other important differences enable consumers to easily differentiate between the authentic and bogus products. The real pills are packed in taller bottles with wider caps. In addition, the ribbing is coarser on GSK’s bottle.

These differences in the components make the packaging more difficult and costlier for counterfeiters to copy. They serve as one example of how package design can serve a brand well in multiple dimensions.

Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report